Contact Us

Filters

Filter by Year
Filter by

Filter by Year
Filter by
Clear Filters

Publications

Displayed are Syndax Sponsored Studies. Search results may include information that is not consistent with the product's Full Prescribing Information. Syndax does not recommend uses that are inconsistent with the Full Prescribing Information.

Publication Cell Therapy Transplant Canada (Axatilimab)
Axatilimab for Chronic Graft-Versus-Host Disease: Responses in Fibrosis-Dominant Organs in AGAVE-201

2024

White, Jennifer et al.

View Publication View Presentation
Publication European Society for Blood and Marrow Transplantation (Axatilimab)
Axatilimab for Chronic Graft-Versus-Host Disease: Responses in Fibrosis-Dominant Organs in AGAVE-201

2024

Perez-Simon, Jose A et al.

View Publication
Publication Japanese Society for Transplantation and Cellular Therapy (Axatilimab)
Safety and Pharmacokinetics of Axatilimab: Results From a Phase 1 Double-Blind Dose-Escalation Study

2024

Suzukawa, K et al.

View Publication
Publication Japanese Society for Transplantation and Cellular Therapy (Axatilimab)
Safety and Efficacy of Axatilimab in Patients With Chronic Graft-Versus-Host Disease (AGAVE -201)

2024

Wolff, Daniel et al.

View Publication
Publication Tandem American Society for Transplantation and Cellular Therapy-Center for International Blood and Marrow Transplant Research (Axatilimab)
Safety and Efficacy of Axatilimab in Patients With Chronic Graft-Versus-Host Disease (AGAVE-201)

2024

DeFilipp, Zachariah et al.

View Publication View Presentation
Publication European Hematology Association (Axatilimab)
Axatilimab for Chronic Graft-Versus-Host Disease: Responses in Fibrosis-Dominant Organs in AGAVE-201

2024

Sica, Simona et al.

View Publication View Presentation
Publication European Respiratory Society Congress (Axatilimab)
Efficacy and Safety of Axatilimab at 3 Different Doses in Patients With Chronic Graft-Versus-Host Disease (cGVHD) and Related Bronchiolitis Obliterans Syndrome (BOS): Results of a Pivotal Phase 2 Study

2024

Salhotra, Amandeep et al.

View Publication
Publication New England Journal of Medicine (Axatilimab)
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease

2024

Wolff, Daniel et al.

Request this Publication View Presentation
Publication American Association for Cancer Research (Revumenib)
A First-in-class Menin-MLL1 Antagonist for the Treatment of MLL-r and NPM1 Mutant Leukemias

2020

McGeehan, Gerald et al.

View Publication
Publication American Society of Hematology (Revumenib)
Safety and Efficacy of Menin Inhibition in Patients (Pts) with MLL-Rearranged and NPM1 Mutant Acute Leukemia: A Phase (Ph) 1, First-in-Human Study of SNDX-5613 (AUGMENT 101)

2021

Stein, Eytan et al.

View Publication View Presentation